The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat.

Source:http://linkedlifedata.com/resource/pubmed/id/15582718

Regul. Pept. 2005 Feb 15 125 1-3 85-92

Download in:

View as

Triples

General Info

PMID
15582718